Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Nov 30, 2025 | (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 217.50%956.09K | -152.41%-177.11K | -35.42%-142.14K | -141.58%-416.02K | -346.72%-950.16K | -72.75%301.13K | -49.07%337.97K | 90.90%-104.96K | 386.63%1M | 133.00%385.12K |
| Net income from continuing operations | -147.91%-137.47K | 89.43%-373.85K | -136.34%-329.34K | -2,083.78%-4.18M | -247.21%-790.03K | -33.00%286.93K | -1,101.27%-3.54M | 59.41%-139.35K | 120.38%210.68K | -22.10%-227.54K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.97%-22.54K | ---- |
| Depreciation and amortization | -0.81%56.51K | 58.36%89.22K | 16.36%56.4K | -6.90%220.38K | -7.48%58.61K | -10.47%56.97K | -1.88%56.34K | -7.38%48.47K | 78.33%236.72K | 20.98%63.34K |
| Asset impairment expenditure | --0 | ---- | ---- | 4,575.34%3.47M | 276,528.74%240.49K | -89.51%7.79K | ---- | ---- | 147.61%74.17K | -134.12%-87 |
| Unrealized gains and losses of investment securities | -702.98%-25.33K | -131.26%-3.86K | -148.84%-33.8K | -157.58%-41.96K | -730.13%-44.92K | -75.55%4.2K | -38.41%12.34K | -147.61%-13.58K | -89.46%72.88K | 118.35%7.13K |
| Remuneration paid in stock | --0 | --0 | 1,374.46%131.48K | 67.48%310.9K | --0 | -74.25%6.77K | --295.21K | -93.29%8.92K | 204.81%185.63K | 24,726.17%26.56K |
| Other non cashItems | 5.49%7.51K | -31.76%5.57K | -17.39%4.83K | 10.13%27.22K | 16.30%6.1K | 15.94%7.12K | 31.84%8.16K | -18.19%5.85K | 30.13%24.72K | -37.49%5.25K |
| Change In working capital | 1,636.81%1.05M | -62.68%105.82K | 285.40%28.3K | -201.17%-220.8K | -178.88%-420.41K | -114.03%-68.64K | 23.62%283.52K | 98.52%-15.26K | 74.77%218.25K | 154.63%533K |
| -Change in receivables | 214.18%39.92K | 21.34%20.19K | -1,691.06%-22.77K | 71.82%-8.58K | 149.64%8.31K | -654.49%-34.96K | -96.08%16.64K | 100.33%1.43K | -200.77%-30.46K | -360.18%-16.75K |
| -Change in prepaid assets | -511.37%-172.86K | 33.01%-30.84K | 90.08%-804 | -119.90%-16.87K | -102.70%-4.76K | -92.76%42.02K | 52.87%-46.03K | 98.59%-8.1K | 193.94%84.79K | 539.18%176.56K |
| -Change in payables and accrued expense | 1,669.16%1.19M | -62.78%116.46K | 703.68%51.87K | -219.17%-195.34K | -213.61%-423.97K | 12.11%-75.7K | 422.17%312.91K | 66.97%-8.59K | -27.23%163.92K | 140.05%373.19K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 217.50%956.09K | -152.41%-177.11K | -35.42%-142.14K | -141.58%-416.02K | -346.72%-950.16K | -72.75%301.13K | -49.07%337.97K | 90.90%-104.96K | 386.63%1M | 133.00%385.12K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -55.66%-828.04K | -209.19%-1.66M | -454.63%-698.16K | -77.25%653.81K | 74.26%-535.34K | 78.16%-531.95K | -22.56%1.52M | -96.37%196.87K | 195.01%2.87M | 37.14%-2.08M |
| Net PPE purchase and sale | ---8.22K | --0 | 54.58%-9.36K | 85.31%-10.25K | -1,791.70%-5.24K | --0 | 129.65%15.6K | -356.71%-20.62K | -55.71%-69.81K | 98.47%-277 |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 200.04%3.02M | 142.92%1.01M |
| Net other investing changes | -63.13%-867.74K | -207.14%-1.62M | -416.71%-688.8K | 925.54%664.06K | 82.83%-530.1K | 79.21%-531.95K | 513.61%1.51M | -95.91%217.49K | -286.58%-80.44K | -228.48%-3.09M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -55.66%-828.04K | -209.19%-1.66M | -454.63%-698.16K | -77.25%653.81K | 74.26%-535.34K | 78.16%-531.95K | -22.56%1.52M | -96.37%196.87K | 195.01%2.87M | 37.14%-2.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -103.52%-52.18K | 862.41%931.13K | -14.71%-55.07K | 892.50%1.48M | -9.49%-55.39K | 2,740.95%1.48M | 289.36%96.75K | -68.45%-48.01K | -105.61%-186.36K | -101.99%-50.59K |
| Net issuance payments of debt | 4.36%-51.43K | -2.66%-54.67K | -14.71%-55.07K | 1.31%-210.43K | -9.49%-55.39K | 4.28%-53.77K | -4.22%-53.25K | 13.27%-48.01K | -58.38%-213.22K | 5.02%-50.59K |
| Net common stock issuance | --0 | ---- | ---- | --1.54M | --0 | 5,248.15%1.39M | --150K | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | 455.56%150K | --0 | ---- | ---- | ---- | --27K | --0 |
| Net other financing activities | ---751 | ---- | ---- | -1,757.64%-2.68K | --0 | ---- | ---- | ---- | 99.83%-144 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -103.52%-52.18K | 862.41%931.13K | -14.71%-55.07K | 892.50%1.48M | -9.49%-55.39K | 2,740.95%1.48M | 289.36%96.75K | -68.45%-48.01K | -105.61%-186.36K | -101.99%-50.59K |
| Net cash flow | ||||||||||
| Beginning cash position | -28.47%4.95M | 16.72%5.87M | 39.97%6.99M | 293.93%4.99M | 25.12%8.38M | -14.71%6.92M | -8.84%5.03M | 293.93%4.99M | -1.10%1.27M | 104.87%6.7M |
| Current changes in cash | -93.94%75.86K | -146.47%-910.26K | -2,139.56%-895.37K | -53.50%1.71M | 11.69%-1.54M | 190.30%1.25M | -24.09%1.96M | -98.96%43.9K | 7,146.74%3.69M | 9.51%-1.74M |
| Effect of exchange rate changes | -180.21%-169.54K | 83.73%-11.37K | -2,569.26%-224.14K | 621.03%281.3K | 276.45%148.17K | 927.97%211.38K | -579.84%-69.85K | -179.02%-8.4K | 2.06%39.01K | 153.17%39.36K |
| End cash Position | -42.08%4.86M | -28.47%4.95M | 16.72%5.87M | 39.97%6.99M | 39.97%6.99M | 25.12%8.38M | -14.71%6.92M | -8.84%5.03M | 293.93%4.99M | 293.93%4.99M |
| Free cash from | 214.77%947.86K | -150.09%-177.11K | -20.64%-151.5K | -145.80%-426.28K | -348.26%-955.4K | -72.46%301.13K | -42.04%353.57K | 89.15%-125.58K | 336.28%930.69K | 132.47%384.84K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.